The Reversibility Threshold of Peri-Implant Inflammation: A Dynamical-Systems Theory of How Repeated Disturbances Could Shift Peri-Implant Tissues Into a Persistent Disease State
- Paper type
- Theoretical scientific investigation with a proposed empirical test
- Status
- Original Work · Working Paper
Contents
Abstract
Background. Peri-implant mucositis is defined as reversible and peri-implantitis as progressive, and the first is regarded as the precursor of the second. How a reversible state becomes a persistent one is not explained. Experimental mucositis resolves at the biomarker level after three weeks of plaque accumulation, yet clinical signs lag and crevicular fluid volume remains elevated. In dogs, experimentally induced peri-implantitis continues to progress after the ligatures that provoked it are removed. In patients, bone loss follows a non-linear, accelerating course. These are the features of a system with more than one stable state.
Objective. To formulate a minimal dynamical model of peri-implant inflammation that exhibits a reversibility threshold, to identify the slow variables through which repeated disturbances could lower that threshold, and to derive testable predictions.
Theory. Inflammation is modeled with a saturating self-amplifying term, linear resolution, and an external drive from biofilm and mechanical or particulate insults. For a range of drive the model has two stable states separated by an unstable threshold, with hysteresis. Slow variables (niche depth, cleanability of exposed implant surface, and innate immune training) are changed by each inflammatory episode and relax slowly or not at all; their accumulation moves the threshold toward the healthy state. Near the threshold, recovery from a perturbation slows.
Proposed test. Recovery time after a standardized, brief, site-specific plaque challenge is proposed as a measurable index of distance from the threshold. Reanalysis of existing experimental mucositis data, a prospective recovery-time study, and an animal experiment with repeated on–off challenges are outlined.
Central hypothesis. Recovery from a standardized challenge lengthens with each prior inflammatory episode and is longer at sites that subsequently develop peri-implantitis.
Conclusions. The theory organizes existing observations and yields a falsifiable prediction. It is not validated, makes no claim of predictive performance, and reports no data.
Keywords: peri-implant mucositis; peri-implantitis; bistability; hysteresis; critical slowing down; dysbiosis; resilience; mathematical model
1. Introduction
The classification of peri-implant diseases rests on a distinction between two states. Peri-implant mucositis is inflammation of the soft tissue without loss of supporting bone, caused by plaque and reversible when plaque is controlled. Peri-implantitis is inflammation with progressive bone loss [1–3]. Mucositis is assumed to precede peri-implantitis, and its treatment is the basis of prevention [4, 5]. Among patients with mucositis followed for five years, peri-implantitis developed in 43.9% of those without preventive maintenance and in 18.0% of those with it [6].
The transition between the two states is where the framework is thinnest. A consensus report describes the conversion as incompletely understood [2], and a recent clinical study begins from the observation that the pattern of conversion is unclear and that available protocols do not yield complete resolution of mucositis; in that study clinical resolution was recorded in 30% of cases after standard treatment [7]. If mucositis is reversible, incomplete resolution needs explaining. If peri-implantitis is the same process carried further, the abruptness with which it accelerates needs explaining: bone loss in affected implants follows a non-linear, accelerating pattern [8, 9].
Three experimental observations sharpen the problem. In human experimental mucositis, three weeks of undisturbed plaque produces clinical inflammation that reverses at the biomarker level when hygiene resumes, yet three further weeks of plaque control do not return clinical indices to their pre-experimental values [10]. A meta-analysis of such experiments found that interleukin-1β returned to baseline after the resolution phase while crevicular fluid volume remained elevated [11]. And in dogs, peri-implantitis induced by ligatures continues to progress after the ligatures are removed, more so at implants with modified surfaces, whereas lesions at teeth do not behave in this way [12–15]. A state that persists after its cause has been withdrawn is, in the language of dynamics, a second stable state.
Systems with alternative stable states have well-characterized generic properties: thresholds, hysteresis, and a slowing of recovery as a threshold is approached [16–18]. These ideas have been applied to chronic disease [19, 20], and the oral microbiome literature already speaks of regime shifts and of positive feedback between dysbiosis and inflammation [21–23]. They have not, as far as the search could determine, been formalized for the peri-implant tissues or used to derive a measurable quantity.
This manuscript does that. It presents a minimal model, identifies what could move its threshold over time, and proposes recovery time after a standardized challenge as an empirical index of proximity to the threshold. The work is theoretical. It predicts qualitative patterns and scaling relations, and makes no claim about the accuracy with which any individual’s course could be forecast.
2. Background and Current Scientific Evidence
Experimental peri-implant mucositis and its resolution
The human experimental model adapts the classical experimental gingivitis design [24]. After three weeks without oral hygiene, clinical and microbiological changes at implants resembled those at teeth [25]. Biopsies showed an inflammatory infiltrate that increased from about 0.03 mm² at baseline to 0.14 mm² in peri-implant mucosa and 0.26 mm² in gingiva [26]. Later studies added immunological and microbiome endpoints and found differences between the responses at implants and teeth [10, 27], including in participants aged 70 and over [28]. Implant surface influences the experimental lesion in animals [29], and available animal and human models have been reviewed [30].
For the present purpose the important findings concern the return path. Resolution is slower than induction: three weeks of hygiene did not restore clinical baseline after three weeks of plaque [10]. Biomarkers do not all recover together: pooled data indicate resilience for interleukin-1β and non-resilience, over the observation period, for crevicular fluid volume [11]. Individuals differ, and in experimental gingivitis consistent high and low responders can be identified [31]. No study has repeated the challenge in the same individuals to see whether the return path changes.
Persistence after removal of the cause
The ligature model in dogs induces peri-implant bone loss by placing a ligature that promotes submarginal plaque. When ligatures were removed after bone loss was established, lesions at some implants progressed spontaneously during continued plaque accumulation [12]; progression after ligature removal was confirmed at commercially available implants of different types and was associated with severe inflammation [13, 14]; and in a direct comparison the bone loss following ligature removal was significantly larger at implants with a modified surface than at implants with a turned surface or at teeth [15]. The earlier canine work had shown that the peri-implant lesion extends toward the bone in a way the periodontal lesion does not [32]. In human tissue, peri-implantitis lesions were more than twice as large as periodontitis lesions and contained greater proportions of inflammatory cells [33].
These experiments show that, beyond some point, the peri-implant lesion sustains itself under conditions that did not produce it in the first place. Plaque alone, before ligation, caused mucositis. Plaque alone, after ligation, maintained progressive bone loss.
Feedback between microbiota and inflammation
The ecological plaque hypothesis holds that environmental change selects for a disease-associated community [21]. Its modern elaboration adds reciprocity: dysbiotic communities provoke inflammation, and inflammation supplies tissue-breakdown products that favor those communities, which are in this sense inflammophilic [23, 34–36]. Reviews of microbial resilience describe positive feedback loops that can produce an abrupt and self-maintaining shift in community structure [22]. Longitudinal sampling during induction of gingival inflammation has characterized community dynamics across oral niches [37]. The reciprocity is described qualitatively. It has the structure required for bistability, since mutual reinforcement between two variables is a positive feedback loop [38].
Mathematical models of inflammation and of periodontal disease
Low-dimensional models of acute inflammation reproduce healthy resolution and several pathological outcomes depending on parameters and initial conditions, and their bifurcations have been analyzed [39, 40]. Periodontitis has been modeled as a non-linear dynamical process with chaotic properties using cellular automata [41], and an omics-based model of experimental periodontitis identified monocyte recruitment as the principal reaction regulating bone resorption [42]. The search identified no dynamical model specific to peri-implant tissues, and none in periodontology that has been used to derive recovery time as an observable.
Critical transitions and their indicators
When a system with alternative stable states approaches the point at which one state disappears, the rate at which it recovers from small perturbations falls toward zero. This critical slowing down is generic, and recovery rate is a practical indicator of resilience [17, 18]. Statistical signatures in time series, rising variance and autocorrelation, follow from it [43]. In medicine, slowing of recovery has been proposed as a risk marker for transitions in chronic disease [19, 20] and has been examined in mood dynamics before depressive episodes [44]. Resolution of inflammation is itself an active, regulated process [45], which gives the recovery rate a biological basis.
Summary
It is established that experimental mucositis resolves incompletely and slowly, that ligature-induced peri-implantitis in dogs can persist and progress after ligature removal, that clinical bone loss accelerates, and that dysbiosis and inflammation reinforce each other. Generic theory for systems with thresholds is mature. The two bodies of work have not been joined for the peri-implant case.
3. Research Gap
The definition of mucositis as reversible and peri-implantitis as progressive describes two regimes without a theory of the boundary between them. Three things are missing. There is no model that states the conditions under which peri-implant inflammation persists after its initiating cause is reduced. There is no account of how a history of inflammatory episodes could change those conditions, although clinical experience suggests that it does. And there is no measurable quantity that indicates how close a site is to the boundary before bone is lost.
4. Research Objective and Central Hypothesis
The objective is to construct a minimal dynamical theory of the transition from reversible to persistent peri-implant inflammation and to derive from it a prediction that can be tested with existing clinical methods.
The central hypothesis is that peri-implant tissues possess two stable inflammatory states over a range of microbial and mechanical drive; that each inflammatory episode shifts slowly relaxing or non-relaxing variables in a direction that narrows the basin of the healthy state; and that, as a measurable consequence, the time required for inflammatory markers to recover after a brief standardized plaque challenge increases with the number and severity of prior episodes and is longer at sites that later develop peri-implantitis.
The hypothesis is refuted if recovery time after a standardized challenge shows no dependence on inflammatory history, or bears no relation to subsequent disease, in adequately powered studies. The theory as a whole would be undermined by evidence that the transition to peri-implantitis is gradual and fully reversible at every stage when the drive is reduced.
5. Scientific and Theoretical Framework
A minimal bistable model
Let I(t)≥0 be a scalar measure of the inflammatory state of the peri-implant soft tissue, scaled to be dimensionless. Its dynamics are taken to be
dI/dt=b+(k I^2)/(θ^2+I^2)−δ I (1)
The term b is the external drive: stimulation by biofilm at the mucosal margin and by any other continuing insult, such as mechanical disturbance of the mucosal seal or particulate debris. The second term is self-amplification: inflammation recruits and activates cells that produce more inflammatory mediators, increases crevicular fluid flow that feeds an inflammophilic microbiota [23], and generates tissue-breakdown products that act as further stimuli. The term saturates at rate k and is half-maximal at I=θ. The third term is resolution at rate δ [45].
The sigmoidal amplification term is the simplest form that gives a threshold. It collapses the microbial feedback and the host feedback into one expression. A two-variable version with explicit biofilm load B, carrying capacity increasing with I, and removal rate set by hygiene behaves in the same way when the microbial variable equilibrates faster than the tissue response, and is given in Section 7.4.
Steady states, threshold, and hysteresis
Steady states satisfy b=δI−kI^2/(θ^2+I^2). When k/(δθ) exceeds a critical value, this relation is S-shaped: for b between two fold values b_1<b_2 there are three steady states, a stable low state I_L, a stable high state I_H, and an unstable intermediate state I_U (Figure 1). The low state corresponds to health or contained mucositis, and the high state to a self-sustaining lesion. The intermediate state is the reversibility threshold: a perturbation that leaves I below I_U decays back to I_L, and one that carries I above I_U grows to I_H.
Hysteresis follows. Starting in the low state, the drive must exceed b_2 for the system to jump to the high state. Once there, reducing the drive to its previous value does not restore the low state. The drive must fall below b_1. If b_1 is at or below zero, the high state cannot be left by reducing drive alone, and something must act on the state variable directly.
Slow variables and the ratchet
Equation (1) with fixed parameters does not explain why repeated episodes should matter. That requires variables that are changed by inflammation and that recover slowly or not at all. Three are proposed, each with independent support.
Niche depth. Inflammation degrades supracrestal connective tissue and deepens the sulcus. A deeper, less ventilated niche supports more biofilm for a given hygiene effort, which raises b. Soft-tissue dimensions recover over weeks after inflammation resolves, on the evidence of barrier formation times, and incompletely if attachment has migrated apically.
Cleanability of the exposed surface. Once bone is lost and a moderately rough, threaded surface is exposed to the pocket, mechanical plaque removal becomes much less effective. This raises b for a given hygiene effort and does not reverse spontaneously. It is the most plausible explanation for the canine finding that progression after ligature removal is greater at modified than at turned surfaces [14, 15].
Innate immune training. Inflammatory episodes can leave myeloid progenitors and stromal cells in a hyperresponsive state [46, 47], which would raise the amplification gain k or lower θ. Its relevance at implants is hypothetical.
Let s denote a slow variable with dynamics
ds/dt=ϵ(α I−s/τ_s), ϵ≪1 (2)
so that s rises during inflammation and relaxes with time constant τ_s/ϵ, which may be very long. Let the drive or gain depend on s, for example b=b_0+βs. Each inflammatory episode of duration T_e and mean intensity I increases s by approximately ϵαIT_e. If episodes recur at intervals shorter than the relaxation time, s accumulates. The effective drive rises toward b_2, or equivalently the threshold I_U falls toward I_L, until an episode that would previously have resolved carries the system over. When the slow variable does not relax at all, as with exposed rough surface, the process is a ratchet.
Recovery rate as an observable
Near the low state, a small perturbation x=I−I_L decays as e^(−λt) with
λ=δ−(2 k θ^2 I_L)/((θ^2+I_L^2)^2) (3)
At the fold b=b_2, λ=0. As the drive approaches the fold, or as slow variables move the fold toward the current drive, λ falls and recovery slows. The recovery half-time t_(1/2)=ln2/λ therefore measures distance from the threshold without the threshold being crossed. This is the bridge from theory to measurement.
6. Methodology
The theory is tested in three steps of increasing cost. Each can refute it.
Step 1: reanalysis of existing experimental mucositis data
Aim. To determine whether recovery kinetics after experimental mucositis can be estimated from published designs and whether they vary with baseline characteristics that the theory identifies as slow variables.
Data. Individual participant data from published human experimental peri-implant mucositis studies with at least two observations during the resolution phase [10, 27, 28], sought from the original investigators.
Analysis. For each participant and marker (crevicular fluid volume, interleukin-1β, gingival or mucosal index, bleeding), an exponential return toward baseline is fitted to the resolution-phase observations to estimate λ. Mixed models relate λ to baseline probing depth, history of periodontitis, age, and implant surface exposure. The comparison between implants and teeth within participants tests the prediction that recovery is slower at implants. The reported difference in resilience between interleukin-1β and crevicular fluid volume [11] is examined at the individual level.
Limits. Existing studies have few resolution-phase time points and were not designed for this purpose. A null finding from sparse data would be weak evidence against the theory. A clear dependence of recovery rate on baseline slow variables would be encouraging.
Step 2: prospective recovery-time study
Design. Prospective cohort with a standardized perturbation, with the experimental component reported to SPIRIT [48] and the observational follow-up to STROBE [49].
Participants. Adults with implants in function for at least one year and peri-implant health or mucositis by current case definitions [50], stratified by number of documented prior mucositis episodes and by history of periodontitis. Sites with any radiographic bone loss beyond initial remodeling are excluded from the challenge.
Challenge. After professional cleaning and a two-week run-in with verified plaque control, a custom stent prevents cleaning of the test implant for a short period. The duration should be the shortest that elicits a measurable response; seven to ten days is proposed for piloting, shorter than the three weeks used in classical designs, to limit risk. Hygiene then resumes with professional cleaning at the end of the challenge.
Measurements. Crevicular fluid volume and a small biomarker panel, bleeding on probing, and a mucosal index at baseline, end of challenge, and days 2, 4, 7, 10, 14, 21, and 28 of recovery. The dense early sampling is what permits estimation of λ.
Primary outcome. Recovery half-time of crevicular fluid volume, chosen because it is continuous, non-invasive, repeatable, and was the least resilient marker in pooled data [11].
Follow-up. Participants are followed in routine maintenance for at least three years for incident peri-implantitis by standard criteria [50].
Hypotheses tested. Recovery half-time increases across strata of prior episodes. Recovery half-time is longer at sites that later develop peri-implantitis. The second is exploratory and concerns association; evaluating recovery time as a predictor would require a separate study designed and reported as a prediction-model investigation, which this protocol does not attempt.
Sample size. The between-person variance of recovery half-time is unknown. The pilot phase (about 20 participants) estimates it together with the within-person repeatability from a second challenge in a subset. The main study is then sized for the trend across history strata. No number is asserted here.
Safety. The challenge induces transient mucositis by design. Stopping rules: suppuration, pain, or probing depth increase of 2 mm or more triggers immediate cleaning and withdrawal of the site. All sites receive professional cleaning at the end of the challenge and are verified to have returned to baseline or are treated. Participants with a history of peri-implantitis at any implant are excluded. An independent monitor reviews adverse events.
Step 3: animal experiment with repeated on–off challenge
Aim. To test the ratchet directly, which cannot be done ethically in humans.
Design. In a canine or minipig model with implants of turned and moderately rough surfaces, plaque accumulation is allowed for a fixed period and then reversed by cleaning for a fixed recovery period, for one, two, three, or four cycles in different groups, with a final observation period under plaque control. A separate arm receives a single ligature episode of graded duration to locate the threshold in terms of bone exposure.
Outcomes. Recovery rate of clinical and crevicular fluid measures in each cycle; histological size of the infiltrate; bone level; and the proportion of sites in which inflammation persists or bone loss continues during the final plaque-controlled period.
Predictions. Recovery slows with each cycle. The proportion of persistent sites rises non-linearly with cycle number. Persistence is more frequent at rough surfaces once any surface is exposed. Reporting follows ARRIVE 2.0 [51].
Model fitting
If Steps 1 and 2 yield recovery curves, the parameters δ and the ratio k/θ can be bounded from the observed range of λ and of steady-state marker levels in health and mucositis. The model is then fitted hierarchically with individual-level parameters. Fitting is not a validation. The model is supported only to the extent that parameters estimated from one set of observations predict another, such as the response to a second challenge.
Ethics
Step 1 uses de-identified existing data under data-sharing agreements. Step 2 requires institutional review board approval, informed consent that describes the deliberate induction of transient inflammation, and independent safety monitoring. Step 3 requires institutional animal care and use committee approval.
7. Analytical Development
Condition for bistability
Define the dimensionless variables y=I/θ, β=b/(δθ), and g=k/(δθ). Steady states satisfy
β=y−(g y^2)/(1+y^2) (4)
The right-hand side is monotonic in y, and the system has a single state, unless its derivative changes sign, which requires
1−(2 g y)/((1+y^2)^2)=0 (5)
to have real positive roots. The maximum of 2y/(1+y^2)^2 over y>0 is 3√(3)/8, attained at y=1/√(3), so bistability requires
g=k/(δ θ)>8/(3√(3))≈1.54 (6)
The interpretation is direct. A persistent state is possible only when the maximal rate of self-amplification is sufficiently large relative to the product of the resolution rate and the level of inflammation at which amplification engages. Anything that strengthens amplification, weakens resolution, or lowers the engagement level moves a site from a regime in which inflammation is always reversible into one in which it can lock in. This offers a formal reading of the difference between teeth and implants in the canine experiments: if the peri-implant tissues have a higher gain or a lower resolution rate, for which the larger lesions at implants are indirect evidence [33], the same challenge can be reversible at a tooth and persistent at an implant.
Accumulation under repeated episodes
From equation (2), with episodes of duration T_e and intensity I separated by quiescent intervals T_q, and writing τ=τ_s/ϵ for the relaxation time, the slow variable just after the nth episode is approximately
s_n≈ϵ α I T_e (1−e^(−n(T_e+T_q)/τ))/(1−e^(−(T_e+T_q)/τ)) (7)
for T_e≪τ. When the interval between episodes is long compared with τ, s_n does not grow with n: each episode is forgotten. When it is short, s_n grows nearly linearly with n up to a plateau of about ϵαIT_e τ/(T_e+T_q). Persistence results if that plateau exceeds the margin (b_2−b_0)/β. The condition for a site never to tip under recurrent episodes is therefore
ϵ α β I T_e τ/(T_e+T_q)<b_2−b_0 (8)
The left side grows with episode intensity, episode duration, and the relaxation time of the slow variable, and falls with the interval between episodes. Maintenance intervals enter through T_e and T_q. The inequality gives formal expression to the clinical finding that preventive maintenance reduces conversion [6] and predicts that its benefit depends on the ratio of the maintenance interval to the relaxation time of the slowest relevant variable. For a variable that does not relax, τ→∞, the left side grows without bound as episodes accumulate, and tipping is a matter of time unless episodes are prevented altogether.
Recovery time near the threshold
Near the fold, to leading order, λ∝√(b_2−b), a general property of saddle-node bifurcations [52]. Recovery half-time therefore diverges as the inverse square root of the remaining margin. A site at half the margin of another recovers about 1.4 times more slowly; one at a tenth of the margin, about 3 times more slowly. The square-root dependence means that recovery time changes modestly until a site is close to the threshold and then rises steeply. As a consequence, a recovery-time test would be relatively insensitive in sites far from the threshold and most informative in those near it, which is where information is most needed.
Two-variable form
With biofilm load B explicit,
dB/dt=r B(1−B/(K_0+K_1I))−c B, dI/dt=a B−δ I+(k_hI^2)/(θ^2+I^2) (9)
where r is the growth rate, K_0+K_1I a carrying capacity that increases with inflammation, c the removal rate by hygiene, a the inflammatory stimulus per unit biofilm, and k_h a host-intrinsic amplification. When B equilibrates quickly, B^*=(K_0+K_1I)(1−c/r) for c<r, and substitution gives a one-variable equation of the form of equation (1) with b=aK_0(1−c/r) and an effective resolution rate δ−aK_1(1−c/r). Two points follow. Hygiene, through c, reduces the drive and also increases the effective resolution rate, so it acts on both the position of the system and the position of the threshold. And the microbial feedback alone, with k_h=0, yields a linear system without bistability; a threshold requires a saturating non-linearity somewhere, whether in the host response as written or in the dependence of community composition on inflammation. Which of these is operative is an empirical question the model raises and cannot answer.
8. Discussion
The theory proposes that reversibility is a property of where a site sits in a landscape with two basins, and that the landscape itself is reshaped by the site’s history. Several observations fit this view: slow and incomplete clinical recovery after experimental mucositis, persistence of experimental peri-implantitis after ligature removal, dependence of that persistence on surface, accelerating bone loss, and the protective effect of maintenance. The theory also yields a quantity that can be measured before any bone is lost.
It could be wrong in several ways. The simplest alternative is that there is no threshold: inflammation and tissue loss increase continuously with cumulative microbial exposure, peri-implantitis is mucositis that has lasted long enough, and persistence after ligature removal in dogs reflects only that plaque accumulation was allowed to continue. Under that account, recovery time would be unrelated to history once current plaque and inflammation are accounted for. The proposed studies distinguish the two, since the continuous account predicts no ratchet and no divergence of recovery time.
A second alternative locates the non-linearity entirely in the hard tissue. Soft-tissue inflammation may be fully reversible at every stage, with irreversibility entering only when bone is lost and rough surface is exposed. That is a special case of the present theory in which the only slow variable is surface exposure and the reversibility threshold coincides with the first bone loss. It would make recovery time uninformative before bone loss, because the soft-tissue dynamics would be far from any fold. The data on incomplete clinical recovery after a single three-week challenge [10] argue weakly against this, and Step 2 tests it.
Third, the scalar variable I compresses a spatially organized lesion with many cell types into one number. Real lesions extend apically, and the canine histology suggests that what distinguishes the peri-implant lesion is its lack of encapsulation and its extension toward bone [32]. A spatial model, in which the lesion front advances when local amplification exceeds local resolution, might be more faithful and would turn the threshold into a condition for front propagation. The scalar model should be seen as the mean-field version of such a description.
The role of non-microbial disturbances deserves comment. The drive b includes any continuing stimulus, and transient insults act as perturbations to I. In a bistable system a transient insult of sufficient size can move the state across the threshold even when the sustained drive is unchanged. Mechanical disruption of the seal, residual cement, and particulate debris are candidates. The theory therefore accommodates a class of events that a purely plaque-based account treats as modifiers, and it predicts that their effect depends on how close the site already is to the threshold. It does not address whether any particular insult is causal in practice.
The theory has implications for how treatment is understood. Hysteresis means that the conditions sufficient to maintain health are not sufficient to restore it. Reducing the drive to the level at which the site was once healthy may not bring a self-sustaining lesion back, which accords with the limited efficacy of non-surgical therapy in established peri-implantitis and gives a rationale for interventions that act on the state or on the slow variables: reducing pocket depth, decontaminating or smoothing exposed surface, and resolving inflammation pharmacologically. It also means that the most efficient time to intervene is before the transition, when small reductions in drive or episode frequency keep the slow variables from accumulating.
Finally, the recovery-time test has practical uncertainties that theory cannot resolve. Crevicular fluid volume is variable and sensitive to sampling technique. The perturbation must be large enough to measure and small enough to be safe. And slowing down is detectable only close to the threshold. Whether the test has adequate reliability and dynamic range is the first thing the pilot phase must establish.
9. Clinical Significance
If the central hypothesis holds, three consequences follow. Risk would be understood as proximity to a threshold that moves with history, in addition to a list of static indicators, and a site’s record of inflammatory episodes would carry prognostic meaning. Maintenance intervals could be reasoned about in relation to the relaxation times of the slow variables, with shorter intervals justified where those times are long. And a functional test of tissue resilience, recovery after a brief standardized challenge, would become a candidate tool for identifying sites near the transition while they are still, by definition, reversible.
These are prospects. Nothing here supports changing maintenance schedules or deliberately challenging implants in clinical practice.
10. Limitations
The model is minimal by design, and its functional forms are chosen for tractability. The inflammatory state is not a single measurable quantity, and different markers recover on different time scales, so that λ depends on the marker chosen. Parameter values are unknown, and Figure 1 uses arbitrary ones. The slow variables are proposed from indirect evidence; innate immune training at implants is hypothetical. The canine ligature model differs from human disease in induction and time course, and persistence there occurred under continued plaque accumulation. Existing human data have sparse resolution-phase sampling. Deliberately inducing mucositis, even briefly, carries risk and will exclude the patients of greatest interest, those with prior peri-implantitis. The scalar model ignores spatial structure and bone. The literature was assessed from abstracts and index records. The theory makes no quantitative prediction for individuals.
11. Future Validation
Beyond the three steps described, intensive longitudinal sampling during routine maintenance, in which the interval between professional cleanings serves as a natural perturbation, could test for rising variance and autocorrelation of crevicular fluid markers before clinical transitions, using established methods [43]. A spatial extension of the model should be compared with histological data on lesion extension. Mechanistic work could determine which non-linearity generates the threshold by examining whether community composition or host response shows switch-like dependence on the other. Independent replication of any recovery-time finding in a second cohort is required before the measure is considered further.
12. Conclusion
The boundary between reversible and persistent peri-implant inflammation has been drawn by definition. A minimal dynamical model with self-amplifying inflammation and linear resolution has two stable states when amplification is strong enough relative to resolution, and slow variables altered by each inflammatory episode can move the threshold between them. The model accounts for persistence after removal of the cause, for the dependence of persistence on implant surface, and for the benefit of maintenance, and it predicts that recovery from a standardized challenge slows as the threshold approaches. That prediction can be tested with existing clinical methods. The theory is offered as a framework for such tests and has not been validated.
Cite this paper
Jain S, Gupta A. The Reversibility Threshold of Peri-Implant Inflammation: A Dynamical-Systems Theory of How Repeated Disturbances Could Shift Peri-Implant Tissues Into a Persistent Disease State. Working paper. Center for Implant Dentistry; 2026. Available from: https://bayareaimplantdentistry.com/clinician-research-and-publications/reversibility-threshold-peri-implant-inflammation
References
- Berglundh T, Armitage G, Araujo MG, Avila-Ortiz G, Blanco J, Camargo PM, et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018;45 Suppl 20:S286-S291. doi:10.1111/jcpe.12957 (opens in a new tab). PMID: 29926491 (opens in a new tab).
- Heitz-Mayfield LJA, Salvi GE. Peri-implant mucositis. J Periodontol. 2018;89 Suppl 1:S257-S266. doi:10.1002/JPER.16-0488 (opens in a new tab). PMID: 29926954 (opens in a new tab).
- Schwarz F, Derks J, Monje A, Wang HL. Peri-implantitis. J Periodontol. 2018;89 Suppl 1:S267-S290. doi:10.1002/JPER.16-0350 (opens in a new tab). PMID: 29926957 (opens in a new tab).
- Jepsen S, Berglundh T, Genco R, Aass AM, Demirel K, Derks J, et al. Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol. 2015;42 Suppl 16:S152-7. doi:10.1111/jcpe.12369 (opens in a new tab). PMID: 25626479 (opens in a new tab).
- Herrera D, Berglundh T, Schwarz F, Chapple I, Jepsen S, Sculean A, et al. Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline. J Clin Periodontol. 2023;50 Suppl 26:4-76. doi:10.1111/jcpe.13823 (opens in a new tab). PMID: 37271498 (opens in a new tab).
- Costa FO, Takenaka-Martinez S, Cota LO, Ferreira SD, Silva GL, Costa JE. Peri-implant disease in subjects with and without preventive maintenance: a 5-year follow-up. J Clin Periodontol. 2012;39(2):173-81. doi:10.1111/j.1600-051X.2011.01819.x (opens in a new tab). PMID: 22111654 (opens in a new tab).
- Rakic M, Tatic Z, Radovanovic S, Petkovic-Curcin A, Vojvodic D, Monje A. Resolution of peri-implant mucositis following standard treatment: A prospective split-mouth study. J Periodontol. 2024;95(9):842-852. doi:10.1002/JPER.23-0507 (opens in a new tab). PMID: 38041803 (opens in a new tab).
- Derks J, Schaller D, Håkansson J, Wennström JL, Tomasi C, Berglundh T. Peri-implantitis - onset and pattern of progression. J Clin Periodontol. 2016;43(4):383-8. doi:10.1111/jcpe.12535 (opens in a new tab). PMID: 26900869 (opens in a new tab).
- Fransson C, Tomasi C, Pikner SS, Gröndahl K, Wennström JL, Leyland AH, et al. Severity and pattern of peri-implantitis-associated bone loss. J Clin Periodontol. 2010;37(5):442-8. doi:10.1111/j.1600-051X.2010.01537.x (opens in a new tab). PMID: 20507368 (opens in a new tab).
- Salvi GE, Aglietta M, Eick S, Sculean A, Lang NP, Ramseier CA. Reversibility of experimental peri-implant mucositis compared with experimental gingivitis in humans. Clin Oral Implants Res. 2012;23(2):182-190. doi:10.1111/j.1600-0501.2011.02220.x (opens in a new tab). PMID: 21806683 (opens in a new tab).
- Huamán-Mendoza AA, do Amaral GCLS, Vilela N, Chuquimez-Ventura CV, Rovai ES, Romito GA, et al. Potential Biomarkers Indicating Resistance or Resilience in Experimental Peri-Implant Mucositis: A Systematic Review and Meta-Analysis. Clin Oral Implants Res. 2025;36(5):525-554. doi:10.1111/clr.14427 (opens in a new tab). PMID: 40078114 (opens in a new tab).
- Zitzmann NU, Berglundh T, Ericsson I, Lindhe J. Spontaneous progression of experimentally induced periimplantitis. J Clin Periodontol. 2004;31(10):845-9. doi:10.1111/j.1600-051X.2004.00567.x (opens in a new tab). PMID: 15367187 (opens in a new tab).
- Albouy JP, Abrahamsson I, Persson LG, Berglundh T. Spontaneous progression of peri-implantitis at different types of implants. An experimental study in dogs. I: clinical and radiographic observations. Clin Oral Implants Res. 2008;19(10):997-1002. doi:10.1111/j.1600-0501.2008.01589.x (opens in a new tab). PMID: 18828815 (opens in a new tab).
- Albouy JP, Abrahamsson I, Persson LG, Berglundh T. Spontaneous progression of ligatured induced peri-implantitis at implants with different surface characteristics. An experimental study in dogs II: histological observations. Clin Oral Implants Res. 2009;20(4):366-71. doi:10.1111/j.1600-0501.2008.01645.x (opens in a new tab). PMID: 19309770 (opens in a new tab).
- Carcuac O, Abrahamsson I, Albouy JP, Linder E, Larsson L, Berglundh T. Experimental periodontitis and peri-implantitis in dogs. Clin Oral Implants Res. 2013;24(4):363-71. doi:10.1111/clr.12067 (opens in a new tab). PMID: 23176551 (opens in a new tab).
- Scheffer M, Carpenter S, Foley JA, Folke C, Walker B. Catastrophic shifts in ecosystems. Nature. 2001;413(6856):591-6. doi:10.1038/35098000 (opens in a new tab). PMID: 11595939 (opens in a new tab).
- Scheffer M, Bascompte J, Brock WA, Brovkin V, Carpenter SR, Dakos V, et al. Early-warning signals for critical transitions. Nature. 2009;461(7260):53-9. doi:10.1038/nature08227 (opens in a new tab). PMID: 19727193 (opens in a new tab).
- van Nes EH, Scheffer M. Slow recovery from perturbations as a generic indicator of a nearby catastrophic shift. Am Nat. 2007;169(6):738-47. doi:10.1086/516845 (opens in a new tab). PMID: 17479460 (opens in a new tab).
- Trefois C, Antony PM, Goncalves J, Skupin A, Balling R. Critical transitions in chronic disease: transferring concepts from ecology to systems medicine. Curr Opin Biotechnol. 2015;34:48-55. doi:10.1016/j.copbio.2014.11.020 (opens in a new tab). PMID: 25498477 (opens in a new tab).
- Olde Rikkert MG, Dakos V, Buchman TG, Boer Rd, Glass L, Cramer AO, et al. Slowing Down of Recovery as Generic Risk Marker for Acute Severity Transitions in Chronic Diseases. Crit Care Med. 2016;44(3):601-6. doi:10.1097/CCM.0000000000001564 (opens in a new tab). PMID: 26765499 (opens in a new tab).
- Marsh PD. Are dental diseases examples of ecological catastrophes?. Microbiology (Reading). 2003;149(Pt 2):279-294. doi:10.1099/mic.0.26082-0 (opens in a new tab). PMID: 12624191 (opens in a new tab).
- Rosier BT, Marsh PD, Mira A. Resilience of the Oral Microbiota in Health: Mechanisms That Prevent Dysbiosis. J Dent Res. 2018;97(4):371-380. doi:10.1177/0022034517742139 (opens in a new tab). PMID: 29195050 (opens in a new tab).
- Hajishengallis G. The inflammophilic character of the periodontitis-associated microbiota. Mol Oral Microbiol. 2014;29(6):248-57. doi:10.1111/omi.12065 (opens in a new tab). PMID: 24976068 (opens in a new tab).
- LOE H, THEILADE E, JENSEN SB. EXPERIMENTAL GINGIVITIS IN MAN. J Periodontol (1930). 1965;36:177-87. doi:10.1902/jop.1965.36.3.177 (opens in a new tab). PMID: 14296927 (opens in a new tab).
- Pontoriero R, Tonelli MP, Carnevale G, Mombelli A, Nyman SR, Lang NP. Experimentally induced peri-implant mucositis. A clinical study in humans. Clin Oral Implants Res. 1994;5(4):254-9. doi:10.1034/j.1600-0501.1994.050409.x (opens in a new tab). PMID: 7640340 (opens in a new tab).
- Zitzmann NU, Berglundh T, Marinello CP, Lindhe J. Experimental peri-implant mucositis in man. J Clin Periodontol. 2001;28(6):517-23. doi:10.1034/j.1600-051x.2001.028006517.x (opens in a new tab). PMID: 11350518 (opens in a new tab).
- Schincaglia GP, Hong BY, Rosania A, Barasz J, Thompson A, Sobue T, et al. Clinical, Immune, and Microbiome Traits of Gingivitis and Peri-implant Mucositis. J Dent Res. 2017;96(1):47-55. doi:10.1177/0022034516668847 (opens in a new tab). PMID: 28033066 (opens in a new tab).
- Meyer S, Giannopoulou C, Courvoisier D, Schimmel M, Müller F, Mombelli A. Experimental mucositis and experimental gingivitis in persons aged 70 or over. Clinical and biological responses. Clin Oral Implants Res. 2017;28(8):1005-1012. doi:10.1111/clr.12912 (opens in a new tab). PMID: 27333829 (opens in a new tab).
- Schwarz F, Mihatovic I, Golubovic V, Eick S, Iglhaut T, Becker J. Experimental peri-implant mucositis at different implant surfaces. J Clin Periodontol. 2014;41(5):513-20. doi:10.1111/jcpe.12240 (opens in a new tab). PMID: 24521508 (opens in a new tab).
- Yin D, Zhan S, Liu Y, Yan L, Shi B, Wang X, et al. Experimental models for peri-implant diseases: a narrative review. Clin Oral Investig. 2024;28(7):378. doi:10.1007/s00784-024-05755-7 (opens in a new tab). PMID: 38884808 (opens in a new tab).
- Trombelli L, Tatakis DN, Scapoli C, Bottega S, Orlandini E, Tosi M. Modulation of clinical expression of plaque-induced gingivitis. II. Identification of “high-responder” and “low-responder” subjects. J Clin Periodontol. 2004;31(4):239-52. doi:10.1111/j.1600-051x.2004.00478.x (opens in a new tab). PMID: 15016251 (opens in a new tab).
- Lindhe J, Berglundh T, Ericsson I, Liljenberg B, Marinello C. Experimental breakdown of peri-implant and periodontal tissues. A study in the beagle dog. Clin Oral Implants Res. 1992;3(1):9-16. doi:10.1034/j.1600-0501.1992.030102.x (opens in a new tab). PMID: 1420727 (opens in a new tab).
- Carcuac O, Berglundh T. Composition of human peri-implantitis and periodontitis lesions. J Dent Res. 2014;93(11):1083-8. doi:10.1177/0022034514551754 (opens in a new tab). PMID: 25261052 (opens in a new tab).
- Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018;16(12):745-759. doi:10.1038/s41579-018-0089-x (opens in a new tab). PMID: 30301974 (opens in a new tab).
- Hajishengallis G, Chavakis T, Lambris JD. Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy. Periodontol 2000. 2020;84(1):14-34. doi:10.1111/prd.12331 (opens in a new tab). PMID: 32844416 (opens in a new tab).
- Hajishengallis G, Lamont RJ. Polymicrobial communities in periodontal disease: Their quasi-organismal nature and dialogue with the host. Periodontol 2000. 2021;86(1):210-230. doi:10.1111/prd.12371 (opens in a new tab). PMID: 33690950 (opens in a new tab).
- Keijser BJF, van den Broek TJ, van der Wurff M, Dulos R, Jagers F, Kool J, et al. Oral bacterial community dynamics during induction of gingival inflammation. Front Cell Infect Microbiol. 2025;15:1597690. doi:10.3389/fcimb.2025.1597690 (opens in a new tab). PMID: 40589868 (opens in a new tab).
- Angeli D, Ferrell JE Jr, Sontag ED. Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc Natl Acad Sci U S A. 2004;101(7):1822-7. doi:10.1073/pnas.0308265100 (opens in a new tab). PMID: 14766974 (opens in a new tab).
- Kumar R, Clermont G, Vodovotz Y, Chow CC. The dynamics of acute inflammation. J Theor Biol. 2004;230(2):145-55. doi:10.1016/j.jtbi.2004.04.044 (opens in a new tab). PMID: 15321710 (opens in a new tab).
- Reynolds A, Rubin J, Clermont G, Day J, Vodovotz Y, Bard Ermentrout G. A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. J Theor Biol. 2006;242(1):220-36. doi:10.1016/j.jtbi.2006.02.016 (opens in a new tab). PMID: 16584750 (opens in a new tab).
- Papantonopoulos G, Takahashi K, Bountis T, Loos BG. Mathematical modeling suggests that periodontitis behaves as a non-linear chaotic dynamical process. J Periodontol. 2013;84(10):e29-39. doi:10.1902/jop.2013.120637 (opens in a new tab). PMID: 23537122 (opens in a new tab).
- Fujihara C, Murakami K, Magi S, Motooka D, Nantakeeratipat T, Canela A, et al. Omics-Based Mathematical Modeling Unveils Pathogenesis of Periodontitis in an Experimental Murine Model. J Dent Res. 2023;102(13):1468-1477. doi:10.1177/00220345231196530 (opens in a new tab). PMID: 37800405 (opens in a new tab).
- Dakos V, Carpenter SR, Brock WA, Ellison AM, Guttal V, Ives AR, et al. Methods for detecting early warnings of critical transitions in time series illustrated using simulated ecological data. PLoS One. 2012;7(7):e41010. doi:10.1371/journal.pone.0041010 (opens in a new tab). PMID: 22815897 (opens in a new tab).
- van de Leemput IA, Wichers M, Cramer AO, Borsboom D, Tuerlinckx F, Kuppens P, et al. Critical slowing down as early warning for the onset and termination of depression. Proc Natl Acad Sci U S A. 2014;111(1):87-92. doi:10.1073/pnas.1312114110 (opens in a new tab). PMID: 24324144 (opens in a new tab).
- Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92-101. doi:10.1038/nature13479 (opens in a new tab). PMID: 24899309 (opens in a new tab).
- Li X, Wang H, Yu X, Saha G, Kalafati L, Ioannidis C, et al. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell. 2022;185(10):1709-1727.e18. doi:10.1016/j.cell.2022.03.043 (opens in a new tab). PMID: 35483374 (opens in a new tab).
- Hajishengallis G, Netea MG, Chavakis T. Trained immunity in chronic inflammatory diseases and cancer. Nat Rev Immunol. 2025;25(7):497-514. doi:10.1038/s41577-025-01132-x (opens in a new tab). PMID: 39891000 (opens in a new tab).
- Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200-7. doi:10.7326/0003-4819-158-3-201302050-00583 (opens in a new tab). PMID: 23295957 (opens in a new tab).
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7. doi:10.1016/S0140-6736(07)61602-X (opens in a new tab). PMID: 18064739 (opens in a new tab).
- Renvert S, Persson GR, Pirih FQ, Camargo PM. Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic considerations. J Periodontol. 2018;89 Suppl 1:S304-S312. doi:10.1002/JPER.17-0588 (opens in a new tab). PMID: 29926953 (opens in a new tab).
- Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. doi:10.1371/journal.pbio.3000410 (opens in a new tab). PMID: 32663219 (opens in a new tab).
- Strogatz SH. Nonlinear dynamics and chaos: with applications to physics, biology, chemistry, and engineering. 2nd ed. Boulder (CO): Westview Press; 2015.

